Literature DB >> 12244193

IL-1 receptor-associated kinase and low molecular weight GTPase RhoA signal molecules are required for bacterial lipopolysaccharide-induced cytokine gene transcription.

Ling-Yu Chen1, Bruce L Zuraw, Fu-Tong Liu, Shuang Huang, Zhixing K Pan.   

Abstract

Proinflammatory cytokines such as IL-1, TNF, IL-6, and IL-8 are produced by leukocytes in response to bacteria or bacterial components. A great deal has been learned during the past few years about the synthesis and release of proinflammatory cytokines by leukocytes; however, relatively little is known about the intracellular events that lead to leukocyte proinflammatory cytokine gene transcription. This study examined the signal transduction pathway of IL-8 induction by bacterial LPS. Stimulation of monocytes with LPS rapidly activated RhoA, and pretreatment of monocytes with a RhoA inhibitor, C3 transferase exoenzyme, effectively blocked LPS-induced IL-8 gene expression. Overexpression of dominant negative RhoA (T19N) or IL-1R-associated kinase completely inhibited LPS-stimulated reporter gene expression. Induction of IL-8 was also inhibited by dominant negative IkappaB kinase and myeloid differentiation protein (MyD88). These results indicate that RhoA and IL-1R-associated kinase are novel signal transducers for LPS-induced Toll-like receptor 4-mediated proinflammatory cytokine synthesis in human monocytes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12244193     DOI: 10.4049/jimmunol.169.7.3934

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Effect of Rho-kinase Inhibitor, Y27632, on Porcine Corneal Endothelial Cell Culture, Inflammation and Immune Regulation.

Authors:  Whayoung Lee; Yuko Miyagawa; Cassandra Long; Matthew Zhang; David K C Cooper; Hidetaka Hara
Journal:  Ocul Immunol Inflamm       Date:  2015-10-16       Impact factor: 3.070

Review 2.  C3 exoenzymes, novel insights into structure and action of Rho-ADP-ribosylating toxins.

Authors:  Martin Vogelsgesang; Alexander Pautsch; Klaus Aktories
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-12-05       Impact factor: 3.000

Review 3.  New players in TLR-mediated innate immunity: PI3K and small Rho GTPases.

Authors:  Monica Ruse; Ulla G Knaus
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  Bacterial LPS up-regulated TLR3 expression is critical for antiviral response in human monocytes: evidence for negative regulation by CYLD.

Authors:  Zhixing K Pan; Chris Fisher; Jian-Dong Li; Yong Jiang; Shuang Huang; Ling-Yu Chen
Journal:  Int Immunol       Date:  2011-04-15       Impact factor: 4.823

5.  Dual role for RhoA in suppression and induction of cytokines in the human neutrophil.

Authors:  Michael B Fessler; Patrick G Arndt; Ingo Just; Jerry A Nick; Kenneth C Malcolm; G Scott Worthen
Journal:  Blood       Date:  2006-10-03       Impact factor: 22.113

6.  Toll-like receptor 2 mediates vascular contraction and activates RhoA signaling in vascular smooth muscle cells from STZ-induced type 1 diabetic rats.

Authors:  Luke Schmidt; Maria Alicia Carrillo-Sepulveda
Journal:  Pflugers Arch       Date:  2015-01-21       Impact factor: 3.657

7.  Regulation of TLR4-mediated signaling by IBP/Def6, a novel activator of Rho GTPases.

Authors:  Qinzhong Chen; Sanjay Gupta; Alessandra B Pernis
Journal:  J Leukoc Biol       Date:  2008-12-12       Impact factor: 4.962

Review 8.  Toll-like receptor signaling in cell proliferation and survival.

Authors:  Xinyan Li; Song Jiang; Richard I Tapping
Journal:  Cytokine       Date:  2009-09-22       Impact factor: 3.861

9.  Lipopolysaccharide-driven Th2 cytokine production in macrophages is regulated by both MyD88 and TRAM.

Authors:  Sumanta Mukherjee; Ling-Yu Chen; Thomas J Papadimos; Shuang Huang; Bruce L Zuraw; Zhixing K Pan
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

10.  RhoA GTPase activation by TLR2 and TLR3 ligands: connecting via Src to NF-kappa B.

Authors:  Maria Manukyan; Perihan Nalbant; Sylvia Luxen; Klaus M Hahn; Ulla G Knaus
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.